Startup
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
TechCrunch Startups · Center
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Read the full story at the original publisher
TechCrunch Startups →
-
Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economicsTechCrunch Startups Center1 day ago
-
Physical AI is more than robots, says the Nvidia veteran now investing in itTechCrunch Startups Center4 days ago
-
Ramp reaches $60B valuation as it pushes deeper into AITechCrunch Startups Center5 days ago
Leave a Reply